NEW YORK (GenomeWeb) – A genomic study of non-invasive bladder cancer has identified genomic subtypes of the disease, along with pathways that are more frequently altered relative to muscle-invasive forms of the disease.

"Our improved ability to identify these specific molecular features of individual tumors should allow a more personalized approach to therapy and disease management in the future," senior author Margaret Knowles, a molecular oncology researcher at Leeds Institute of Cancer and Pathology, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.